Literature DB >> 25633877

Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Francesco Bennardello1, Serelina Coluzzi2, Giuseppe Curciarello3, Tullia Todros4, Stefania Villa5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25633877      PMCID： PMC4317097          DOI： 10.2450/2014.0119-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  104 in total

1.  Etiology and outcome of hydrops fetalis.

Authors:  K M Ismail; W L Martin; S Ghosh; M J Whittle; M D Kilby
Journal:  J Matern Fetal Med       Date:  2001-06

Review 2.  How concerned should we be about missing antibodies to low incidence antigens?

Authors:  George Garratty
Journal:  Transfusion       Date:  2003-07       Impact factor: 3.157

3.  [Demonstration of fetal hemoglobin in erythrocytes of a blood smear].

Authors:  E KLEIHAUER; H BRAUN; K BETKE
Journal:  Klin Wochenschr       Date:  1957-06-15

4.  Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.

Authors:  Kevin J Pirelli; Bradley C Pietz; Susan T Johnson; Holly L Pinder; Daniel B Bellissimo
Journal:  Prenat Diagn       Date:  2010-12       Impact factor: 3.050

5.  Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.

Authors:  G Mari; R L Deter; R L Carpenter; F Rahman; R Zimmerman; K J Moise; K F Dorman; A Ludomirsky; R Gonzalez; R Gomez; U Oz; L Detti; J A Copel; R Bahado-Singh; S Berry; J Martinez-Poyer; S C Blackwell
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

Review 6.  Red blood cell alloimmunization in pregnancy.

Authors:  Kenneth J Moise
Journal:  Semin Hematol       Date:  2005-07       Impact factor: 3.851

7.  The Lui elution technique. A simple and efficient method for eluting ABO antibodies.

Authors:  C S Feng; K C Kirkley; C A Eicher; D S de Jongh
Journal:  Transfusion       Date:  1985 Sep-Oct       Impact factor: 3.157

8.  Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).

Authors:  Slavica Dajak; Vedran Stefanović; Vesna Capkun
Journal:  Transfusion       Date:  2011-01-07       Impact factor: 3.157

9.  Management of pregnancies complicated by anti-E alloimmunization.

Authors:  Saju D Joy; Karen Q Rossi; Dave Krugh; Richard W O'Shaughnessy
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

10.  Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity.

Authors:  M Scheier; E Hernandez-Andrade; A Carmo; V Dezerega; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2004-05       Impact factor: 7.299
View more
  5 in total

1.  Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD.

Authors:  Jelena Lukacevic Krstic; Slavica Dajak; Jasna Bingulac-Popovic; Vesna Dogic; Jela Mratinovic-Mikulandra
Journal:  Transfus Med Hemother       Date:  2016-10-14       Impact factor: 3.747

2.  Frequency of Red Cell Alloantibodies in Pregnant Females of Navsari District: An Experience that Favours Inclusion of Screening for Irregular Erythrocyte Antibody in Routine Antenatal Testing Profile.

Authors:  Manoj Kahar
Journal:  J Obstet Gynaecol India       Date:  2017-03-29

3.  The contribution of iron deficiency to the risk of peripartum transfusion: a retrospective case control study.

Authors:  H VanderMeulen; R Strauss; Y Lin; A McLeod; J Barrett; M Sholzberg; J Callum
Journal:  BMC Pregnancy Childbirth       Date:  2020-04-06       Impact factor: 3.007

4.  Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization.

Authors:  Catalina Acosta; Isra Idris; Rossana Romero; Lilian Ablan; Armyda Montoya Novoa; Awadelkarim Abdalaziz; Alexander Rodriguez
Journal:  Cureus       Date:  2021-11-15

5.  Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial.

Authors:  Rahul Vishwanath Mayekar; Gopalkrishna Vinayak Paradkar; Archana Anilkumar Bhosale; Rekha Sachan; Sumalatha Beeram; Ashok Ramachandra Anand; Shuchita Ramesh Mundle; Yamini Trivedi; Rashmi Md; Kiran Pandharinath Patole; Pradip Wamanrao Sambarey; Gautam Vinod Daftary; James John; Ganesh Harishchandra Divekar
Journal:  Obstet Gynecol Sci       Date:  2020-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.